Health
Coronavirus: how countries aim to get the vaccine first by cutting opaque supply deals – Australian Times
The University of Oxford recently published promising news about the results from the phase one/two trials of the vaccine it is developing for COVID-19.
Duncan Matthews, Queen Mary University of London
The University of Oxford recently published promising news about the results from the phase one/two trials of the vaccine it is developing for COVID-19. The clinical trials, involving 1,077 volunteers in the UK aged 18-55, showed that the AZD1222 vaccine appeared to be safe and generated the all-important dual antibody and T-cell immune response.
The rush to be first. Ivan Krivenko
Yet as encouraging as this is, the public-partnership that unde…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General15 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says